Target intelligence / Profile preview

ST3GAL5 antisense RNA 1 (ST3GAL5-AS1)

Target
ST3GAL5-AS1
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

ST3GAL5 antisense RNA 1 (ST3GAL5-AS1) is a long non-coding RNA transcribed from the region antisense to the ST3GAL5 gene. Its precise biological function, disease association, or mechanistic role has not been established in peer-reviewed literature or major gene annotation databases. As an antisense lncRNA, it may have regulatory roles controlling the expression of the adjacent ST3GAL5 gene (which encodes lactosylceramide alpha-2,3-sialyltransferase, involved in ganglioside biosynthesis), but specific functions for the lncRNA itself remain to be elucidated. ST3GAL5-AS1 is distinct from the protein-coding ST3GAL5 (GM3 synthase) gene, which is an enzyme involved in ganglioside biosynthesis and is implicated in neurological disorders and some cancers, but the antisense RNA described here does not have documented direct involvement in known therapeutic pathways. No clear therapeutic target, receptor, enzyme, transporter, or drug interaction roles have been ascribed to ST3GAL5-AS1. ST3GAL5-AS1 is a long non-coding RNA associated with the ST3GAL5 gene locus, with no documented role as a therapeutic target or clinical biomarker, and lacking known drug interactions or clear biological functions based on current data.

02

Mechanism of action

Not applicable; no therapeutic targeting or known mechanisms related to drugs.

03

Biological functions

Unknown; specific biological functions for ST3GAL5-AS1 are not documented in current gene resources
04

Disease associations

None established; no current literature links this specific antisense RNA to particular diseases or clinical phenotypes

Beyond the preview

Go deeper on ST3GAL5 antisense RNA 1 (ST3GAL5-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ST3GAL5 antisense RNA 1 (ST3GAL5-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call